Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine with or without esketamine for preoperative sedation and anxiety reduction in children undergoing dental surgery
ChiCTR2100044588Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and esketamine in preoperative anxiety and procedural sedation and analgesia (PSA) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Sedation level and Dental anxiety level. Started Feb 2021; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
preoperative anxietyprocedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2100044588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044588.